Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Transdermal Contraceptive System vs Triphasil
NCT00236795Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 1997
- Modality
- Transdermal Patches, Small Molecules
01
Overview
A Phase 3 trial of norelgestromin + ethinyl estradiol in pregnancy, sponsored by Johnson & Johnson. Started Jan 1997; status: completed.
02
Drugs
norelgestromin + ethinyl estradiol
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00236795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236795.